Phase I trial of hypoxia-responsive CEA CAR-T cell therapy in patients with heavily pretreated solid tumor via intraperitoneal or intravenous transfusion.

C-13-60 - Chongqing Precision Biotech

https://meetings.asco.org/abstracts-presentations/239592/

Hangyu Zhang; Zhi Yang; Xudong Zhu; Jie Li; Yang Gao; Yingzi Zhang; Zhou Tong; Qihan Fu; Xuanwen Bao; Bin Li; Qianzhen Zhang; Junjie Shen; Yi Zheng; Lulu Liu; Peng Zhao; Cheng Qian; Weijia Fang

Apr 25, 2024